Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Soho Global Health TbkISX:SOHO +0.42%85 ROA % is 12.86% as of Jun. 2026, which is 53% above its 10-year median of 8.40. GuruFocus rates ISX:SOHO with a GF Score™ of 85/100 and a GF Value™ of Rp805.04 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 122 Medical Distribution companies, PT Soho Global Health Tbk ranks better than 95.08% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. PT Soho Global Health Tbk's annualizedNet Income for the quarter that ended in Jun. 2026 was Rp732,256 Mil.
PT Soho Global Health Tbk's average Total Assets over the quarter that ended in Jun. 2026 was Rp5,695,745 Mil. Therefore, PT Soho Global Health Tbk's annualized ROA % for the quarter that ended in Jun. 2026 was 12.86%.
The historical rank and industry rank for PT Soho Global Health Tbk's ROA % or its related term are showing as below:
ISX:SOHO'
s ROA % Range Over the Past 10 Years
Min: 3.62 Med: 8.4 Max: 13.42
Current: 11.76
During the past 7 years, PT Soho Global Health Tbk's highest ROA % was 13.42%. The lowest was 3.62%. And the median was 8.40%.
ISX:SOHO's ROA % is ranked better than 95.08% of 122
companies
in the Medical Distribution industry
Industry Median: 2.405
vs ISX:SOHO: 11.76
PT Soho Global Health Tbk (ISX:SOHO) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, PT Soho Global Health Tbk's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Soho Global Health Tbk ROA % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Soho Global Health Tbk's ROA % distribution charts can be found below:
* The bar in red indicates where PT Soho Global Health Tbk's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
ROA % is displayed in the 30-year financial page.
PT Soho Global Health Tbk (ISX:SOHO) has a ROA % of 12.86% as of Jun. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PT Soho Global Health Tbk and its competitors. This is 53% above median its historical median of 8.40. Over the past decade, PT Soho Global Health Tbk's ROA % has ranged from 3.62 to 13.42. According to the industry distribution chart, PT Soho Global Health Tbk ranks #6 out of 122 companies in the Medical Distribution industry, placing it in the top 4.9%.
Is PT Soho Global Health Tbk's ROA % too high?
PT Soho Global Health Tbk's current ROA % of 12.86% is 53% above median its 10-year median of 8.40. Over the past 10 years, this metric has ranged from a low of 3.62 to a high of 13.42. The Medical Distribution industry median ROA % is 2.41. PT Soho Global Health Tbk's value of 12.86% is 434.7% above this industry median. Based on the distribution chart, PT Soho Global Health Tbk ranks #6 out of 122 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Soho Global Health Tbk has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Soho Global Health Tbk's ROA % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Soho Global Health Tbk ranks #6 out of 122 companies for ROA %. This places PT Soho Global Health Tbk in the top 5% of its industry — outperforming the majority of peers. The industry median ROA % is 2.41. PT Soho Global Health Tbk's value of 12.86% is 434.7% above this benchmark. Historically, PT Soho Global Health Tbk's own ROA % has ranged from 3.62 to 13.42 over the past decade. While the company's 10-year median is 8.40 vs. the industry median of 2.41, PT Soho Global Health Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Distribution company?
The median ROA % among Medical Distribution companies is 2.41, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Soho Global Health Tbk's current ROA % of 12.86% is 434.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PT Soho Global Health Tbk and its competitors. For the Medical Distribution industry, the median ROA % is 2.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Soho Global Health Tbk's current ROA % is 12.86%, which is 53% above median its own 10-year median of 8.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Soho Global Health Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Soho Global Health Tbk (ISX:SOHO) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp805.04, compared to a current price of Rp1,205.00 — trading 49.7% above its estimated fair value. The current ROA % is 12.86%, which is 53% above median its 10-year median of 8.40 and 434.7% above the Medical Distribution industry median of 2.41. PT Soho Global Health Tbk's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For PT Soho Global Health Tbk (ISX:SOHO), the current ROA % is 12.86% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Soho Global Health Tbk (ISX:SOHO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Soho Global Health Tbk stock appears to be overvalued.
The current stock price of Rp1,205.00 is trading 49.7% above its estimated GF Value™ of Rp805.04.
GuruFocus considers PT Soho Global Health Tbk to be Significantly Overvalued.
Key valuation signals for ISX:SOHO:
ROA %: 12.86% (53% above median its 10-year median of 8.40)
GF Value™: Rp805.04 vs. price of Rp1,205.00 (49.7% above fair value)
Industry Position: 434.7% above the Medical Distribution median (#6 of 122)
No single metric tells the full story. See the ISX:SOHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products, including herbal cures, proprietary medicines, and health foods, under various brand names such as Curcuma Plus, Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho, and Sohobion. Its segment includes Distribution, Consumer health, Alliance, and others. The company generates maximum revenue from the Distribution segment.
85GF Score
Get the complete analysis for ISX:SOHO
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SOHO has been successfully added to your 
